STAT3 and gastric cancer: Further in vivo investigations verified that the combination treatment of circUBE2Q2 knockdown and STAT3 inhibitor had synergistic effects on the inhibition of gastric cancer growth, suggesting that targeting circUBE2Q2 may increase the sensitivity of targeted therapies to gastric cancer (Yang et al., 2021b) (Figure 3B).